title: Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: type 2 diabetes.
abstract: BACKGROUND
  Visceral adiposity index (VAI) has recently been developed based on waist circumference, body mass index (BMI), triglycerides (TGs), and high-density lipoprotein cholesterol (HDL-C). We examined predictive performances for incident diabetes of the VAI per se and as compared to the metabolic syndrome (MetS) and waist-to-height-ratio (WHtR).
  
  
  METHODS
  Participants free of diabetes at baseline with at least one follow-up examination (5,964) were included for the current study. Weibull regression models were developed for interval-censored survival data. Absolute and relative integrated discriminatory improvement index (IDI) and cut-point-based and cut-point-free net reclassification improvement index (NRI) were used as measures of predictive ability for incident diabetes added by VAI, as compared to the MetS and WHtR.
  
  
  RESULTS
  The annual incidence rate of diabetes was 0.85 per 1000 person. Mean VAI was 3.06 (95%CIs 2.99-3.13). Diabetes risk factors levels increased in stepwise fashion across VAI quintiles. Risk gradient between the highest and lowest quintile of VAI was 4.5 (95%CIs 3.0-6.9). VAI significantly improved predictive ability of the MetS. The relative IDI and cut-point free NRI for predictive ability added to MetS by VAI were 30.3% (95%CIs 18.8-41.8%) and 30.7% (95%CIs 20.8-40.7%), respectively. WHtR, outperformed VAI with cut-point-free NRI of 24.6% (95%CIs 14.1-35.2%).
  
  
  CONCLUSIONS
  In conclusion, although VAI could be a prognostic tool for incident diabetes events, gathering information on its components (WC, BMI, TGs, and HDL-C) is unlikely to improve the prediction ability beyond what could be achieved by the simply assessable and commonly available information on WHtR.
authors: Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences (RIES), Shahid Beheshti University of Medical Sciences, Tehran, Iran. mr_bozorgmanesh@endocrine.ac.ir
authors: Mohammadreza
authors: M
authors: Bozorgmanesh
authors: Farzad
authors: F
authors: Hadaegh
authors: Fereidoun
authors: F
authors: Azizi
references: Arch Intern Med. 2007 May 28;167(10):1068-74
references: 17533210
references: Curr Opin Lipidol. 2006 Aug;17(4):404-11
references: 16832164
references: Circulation. 2009 May 5;119(17):2408-16
references: 19364974
references: Am J Clin Nutr. 2002 Apr;75(4):683-8
references: 11916754
references: Ann Med. 2006;38(1):52-63
references: 16448989
references: J Am Coll Nutr. 2007 Jun;26(3):191-5
references: 17634163
references: Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49
references: 18356555
references: J Cardiopulm Rehabil. 2005 Jul-Aug;25(4):226-32; discussion 233-4
references: 16056071
references: Lipids Health Dis. 2010 May 10;9:45
references: 20459710
references: BMC Public Health. 2009 Jun 16;9:186
references: 19531260
references: Am J Nephrol. 2009;29(6):615-9
references: 19151548
references: Diabetes Care. 2009 Nov;32(11):2116-9
references: 19720844
references: Diabetes Care. 2010 Apr;33(4):920-2
references: 20067971
references: Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12
references: 17569110
references: Int J Obes (Lond). 2009 Dec;33(12):1437-45
references: 19752876
references: Lancet. 2005 Sep 24-30;366(9491):1059-62
references: 16182882
references: Diabet Med. 1999 May;16(5):442-3
references: 10342346
references: Trials. 2009 Jan 25;10:5
references: 19166627
references: Ann Nutr Metab. 2008;53(1):13-22
references: 18772585
references: Nature. 2006 Dec 14;444(7121):881-7
references: 17167477
references: Circulation. 2009 Oct 20;120(16):1640-5
references: 19805654
references: BMC Cardiovasc Disord. 2005 Sep 08;5:26
references: 16150143
references: Lipids Health Dis. 2010 Sep 16;9:100
references: 20846382
references: Diabetes Care. 2001 May;24(5):925-32
references: 11347756
references: Stat Med. 1996 Feb 28;15(4):361-87
references: 8668867
references: Am J Cardiol. 1994 Mar 1;73(7):460-8
references: 8141087
references: Trends Endocrinol Metab. 2003 Nov;14(9):398-403
references: 14580758
references: Endocr Pract. 2003 May-Jun;9(3):237-52
references: 12924350
references: Endocrinol Metab Clin North Am. 2003 Dec;32(4):915-33
references: 14711068
references: Circulation. 2004 Jan 27;109(3):433-8
references: 14744958
references: J Endocrinol Invest. 2006;29(3 Suppl):77-82
references: 16751711
references: Diabetes Care. 1999 Sep;22(9):1471-8
references: 10480511
references: Radiology. 1982 Apr;143(1):29-36
references: 7063747
references: JAMA. 2001 May 16;285(19):2486-97
references: 11368702
references: Diabetes Care. 2009 Jul;32(7):1207-12
references: 19564473
references: Diabet Med. 1998 Jul;15(7):539-53
references: 9686693
references: Diabetes Care. 2003 Nov;26(11):3160-7
references: 14578255
references: Diabet Med. 2006 May;23(5):469-80
references: 16681555
references: Diabetes Care. 2010 Jan;33 Suppl 1:S11-61
references: 20042772
references: Am J Prev Med. 2010 Jun;38(6):628-636.e1
references: 20494239
references: Diabetes. 1988 Dec;37(12):1595-607
references: 3056758
references: Obesity (Silver Spring). 2010 Sep;18(9):1836-44
references: 20035284
references: Diabetes Care. 2006 Jan;29(1):151-3
references: 16373916
references: Recent Prog Horm Res. 2004;59:207-23
references: 14749503
references: Am J Clin Nutr. 2003 Nov;78(5):928-34
references: 14594778
references: Eur J Public Health. 2011 Oct;21(5):554-9
references: 20534689
references: PLoS One. 2010 Apr 09;5(4):e10100
references: 20396381